MktsMarkets

Voyager Therapeutics, Inc.
NASDAQ: VYGRKey statistics
VYGR News
Stories mentioning VYGR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,593 | 15,336 | 13,365 | 5,200 | 6,473 | 6,278 | 24,629 | 29,578 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 24,602 | 35,952 | 35,866 | 31,330 | 31,526 | 35,583 | 30,241 | 34,452 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 32,863 | 45,268 | 43,959 | 41,825 | 41,166 | 44,577 | 38,409 | 44,603 |
| Operating Income (Loss) | (30,270) | (29,932) | (30,594) | (36,625) | (34,693) | (38,299) | (13,780) | (15,025) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 435.00 | 404.00 | 400.00 | 427.00 | 418.00 | 200.00 | 20.00 | |
| Pretax Income | (27,923) | (27,417) | (27,809) | (33,367) | (30,984) | (33,903) | (9,001) | (10,117) |
| Tax Provision | 14.00 | 9.00 | 83.00 | 15.00 | 37.00 | 584.00 | 43.00 | 24.00 |
| Net Income (Loss) | (27,937) | (27,426) | (27,892) | (33,382) | (31,021) | (34,487) | (9,044) | (10,141) |
| Earnings Per Share (Basic) | (0.47) | (0.47) | (0.47) | (0.57) | (0.53) | (0.60) | (0.16) | (0.18) |
| Earnings Per Share (Diluted) | (0.47) | (0.47) | (0.47) | (0.57) | (0.53) | (0.60) | (0.16) | (0.18) |
| Weighted Average Shares Outstanding (Basic) | 59,496 | 58,691 | 58,803 | 58,666 | 58,350 | 57,668 | 57,851 | 57,722 |
| Weighted Average Shares Outstanding (Diluted) | 59,496 | 58,691 | 58,803 | 58,666 | 58,350 | 57,668 | 57,851 | 57,722 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VYGR
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is a stock listed on the Nasdaq Stock Market under the ticker symbol VYGR. It last traded at $1.63 (Nov 16, 2026, 4:00 PM ET), down 5.8% on the day. That gives Voyager Therapeutics a market capitalisation of $103.5M.
Over the past 52 weeks VYGR has traded between $1.58 and $5.48.
Revenue for the quarter ended Mar 31, 2026 was $2.6M; a net loss of $27.9M. Revenue was down 59.9% from $6.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.6M | -$27.9M | -1077.4% |
| Dec 31, 2025 | $15.3M | -$27.4M | -178.8% |
| Sep 30, 2025 | $13.4M | -$27.9M | -208.7% |
| Jun 30, 2025 | $5.2M | -$33.4M | -642.0% |
From Voyager Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…